STTR Phase I: Monolithic Multiwavelength Blue-to-IR LED for Biomedical Diagnostics

Information

  • NSF Award
  • 0712295
Owner
  • Award Id
    0712295
  • Award Effective Date
    7/1/2007 - 16 years ago
  • Award Expiration Date
    12/31/2008 - 15 years ago
  • Award Amount
    $ 191,942.00
  • Award Instrument
    Standard Grant

STTR Phase I: Monolithic Multiwavelength Blue-to-IR LED for Biomedical Diagnostics

This Small Business Technology Transfer (STTR) Phase I project will demonstrate the feasibility of a novel multi-wavelength light-emitting diode (LED) for transdermal health monitoring of various blood metabolites simultaneously in real time. With independent control of up to 12 spectrally narrow wavelengths, ranging from deep-UV to mid-IR, from a single 1 mm2 LED die, the company's compact multi-wavelength LED will revolutionize traditional pulse oximetry with unprecedented functionality at a significantly lower cost. In contrast with traditional dual-wavelength pulse oximetry, which primarily measures the ratio of oxygenated to deoxygenated blood, the proposed multi-wavelength LED will enable the real-time analysis several additional metabolites critical to health monitoring via the same noninvasive paradigm. Furthermore, combining 12 LEDs into one self-aligned device precludes the need for expensive packaging and complex optical alignment.<br/><br/>The medical impact of dual-wavelength pulse oximetry, in both saving lives and reducing healthcare costs, has encouraged the development of broader platforms using additional optical wavelengths. Incorporating 3 or more independently controlled wavelengths has been shown to enable the real-time monitoring of multiple health factors while further reducing readout errors - thus saving more lives. Beyond blood oxygen monitoring, a real-time noninvasive assessment of renal and hepatic health can be realized by integrating several wavelengths in the same clinically accepted pulse oximetry paradigm. The proposed multi-wavelength single-die approach surmounts these limitations by providing independent control of several wavelengths from a single, self-aligned, compact LED. Integrating these advanced, cost-effective optical sources into traditional pulse oximetry opens up new markets in noninvasive metabolic monitoring for paramedics, physical therapists, drug discovery, and home healthcare. As a spectroscopic source, other applications include air-quality/pollution monitoring and agricultural/industrial controls.

  • Program Officer
    Juan E. Figueroa
  • Min Amd Letter Date
    5/14/2007 - 17 years ago
  • Max Amd Letter Date
    6/24/2008 - 15 years ago
  • ARRA Amount

Institutions

  • Name
    Valencell Inc.
  • City
    raleigh
  • State
    nc
  • Country
    United States
  • Address
    920 Main Campus Drive
  • Postal Code
    276065219
  • Phone Number
    9194244432

Investigators

  • First Name
    Steven
  • Last Name
    LeBoeuf
  • Email Address
    leboeuf@valencell.com
  • Start Date
    5/14/2007 12:00:00 AM

FOA Information

  • Name
    Technology Transfer
  • Code
    110000
  • Name
    Industrial Technology
  • Code
    308000